company background image
688506 logo

Sichuan Biokin PharmaceuticalLtd SHSE:688506 Stock Report

Last Price

CN¥125.05

Market Cap

CN¥50.9b

7D

-10.9%

1Y

83.4%

Updated

27 Mar, 2024

Data

Company Financials +

Sichuan Biokin Pharmaceutical Co.,Ltd.

SHSE:688506 Stock Report

Market Cap: CN¥50.9b

688506 Stock Overview

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.

688506 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sichuan Biokin PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥125.05
52 Week HighCN¥157.33
52 Week LowCN¥61.11
Beta0
1 Month Change5.01%
3 Month Change-11.63%
1 Year Change83.41%
3 Year Changen/a
5 Year Changen/a
Change since IPO290.17%

Recent News & Updates

Recent updates

Shareholder Returns

688506CN PharmaceuticalsCN Market
7D-10.9%-3.4%-2.2%
1Y83.4%-11.4%-14.8%

Return vs Industry: 688506 exceeded the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 688506 exceeded the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688506's price volatile compared to industry and market?
688506 volatility
688506 Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688506 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688506's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20062,159Yi Zhuhttps://www.baili-pharm.com

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Sichuan Biokin PharmaceuticalLtd's earnings and revenue compare to its market cap?
688506 fundamental statistics
Market capCN¥50.93b
Earnings (TTM)-CN¥763.90m
Revenue (TTM)CN¥561.87m

89.2x

P/S Ratio

-65.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688506 income statement (TTM)
RevenueCN¥561.87m
Cost of RevenueCN¥0
Gross ProfitCN¥561.87m
Other ExpensesCN¥1.33b
Earnings-CN¥763.90m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)-1.90
Gross Margin100.00%
Net Profit Margin-135.96%
Debt/Equity Ratio79.9%

How did 688506 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.